Angus, D., Linde-Zwirble, W., & Lidicker, J. (2001). Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med. 29:1303-1310. doi:10.1097/00003246-200107000-00002.
Castelli, G., Pognani, C., Meisner, M., Stuani, A., Bellomi, D., & Sgarbi, L. (2004). Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care. 8(4):R234-R242. doi:10.1186/cc2877
Durkin, T., Barua, B., Savagatrup, S. (2021). Rapid detection of sepsis: Recent advances in biomarker sensing platforms. ACS Omega. 6(47):31390-31395. doi:10.1021/acsomega.1c04788
Harbarth, S., Holeckova, K., & Froidevaux, C., (2001). Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med. 164(3):396-402. doi:10.1164/ajrccm.164.3.2009052
Müller, B., Becker, K., & Schächinger, H., et al. (2000). Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med. 28(4):977-983. doi:10.1097/00003246-200004000-00011
Pierrakos, C., Velissaris, D., Bisdorff, M., Marshall, J., & Vincent, J. (2020). Biomarkers of sepsis: time for a reappraisal. Crit Care. 24(1):287. doi:10.1186/s13054-020-02993-5
Singer, M., Deutschman, C., Seymour, C., et al. (2016). The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 315(8):801-810. doi:10.1001/jama.2016.0287